GlassScriptPhysician profile
John S Chaffin
NPI 1043215890
$1,631.55
in general payments reported to CMS, 2019-2025
22 companies · $14.40 in 2025
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $808 · 2020: $119 · 2021: $19.47 · 2022: $441 · 2023: $162 · 2024: $67.23 · 2025: $14.40.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $244.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $243.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $327.19 | 2019-2023 | Impella |
| Medtronic Vascular, INC. | $258.22 | 2019-2020 | |
| Medtronic, INC. | $246.12 | 2022-2023 | Octopus, Endurant Iis, Valiant Captivia |
| Paragonix Technologies, INC. | $162.48 | 2022 | |
| Atricure, INC. | $124.93 | 2019 | |
| Corcym INC | $100.96 | 2023-2024 | Mi Detach - Aortic Cross Clamp - Delivery System Kit, Perceval |
| La Jolla Pharmaceutical Company | $64.77 | 2019-2020 | |
| Abbott Laboratories | $42.73 | 2022 | |
| Depuy Synthes Sales INC. | $36.44 | 2022 | |
| Portola Pharmaceuticals, LLC | $34.89 | 2019 | |
| Edwards Lifesciences Corporation | $32.34 | 2020 | |
| Ethicon US, LLC | $28.36 | 2019 | |
| Silk Road Medical, INC. | $25.49 | 2019 | |
| Getinge USA Sales, LLC | $20.27 | 2019 | |
| Surmodics, INC. | $18.90 | 2023 | Sublime 014 Rx Pta Balloon Dilatation Catheter, Pounce Thrombectomy, Pounce Venous Thrombectomy System |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $18.89 | 2020 | |
| Lsi Solutions INC | $17.44 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $16.37 | 2019 | |
| Boston Scientific Corporation | $14.40 | 2025 | Accolade Sr |
| Sumitomo Pharma America, INC. | $14.16 | 2023 | Gemtesa |
| Biomerieux INC | $13.27 | 2019 | |
| Chiesi USA, INC. | $12.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Chaffin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.